Anti-HER2 scFv antibody-directed lentiviral delivery of myrosinase for eradicating HER2+cancer cells after dosing prodrug sinigrin

被引：0
|
作者：
Tarar, Ammar Ahmad [1 ]
Peng, Ching-An [1 ]
机构：
[1] Univ Idaho, Moscow, ID 83843 USA
来源：
CANCER RESEARCH | 2022年 / 82卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3291
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Differential responses of HER2-positive breast cancer cells to anti-HER2 treatment.
    Yu, Rong
    Chiu, Kung Y.
    Shi, Lili
    Zhang, Peter
    Duan, Chun-Xiao
    Lu, Sunny
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [22] Potent inhibition of human gastric cancer by HER2-directed induction of apoptosis with anti-HER2 antibody and caspase-3 fusion protein
    Zhang, De-Xin
    Zhao, Peng-Tao
    Xia, Lin
    Liu, Li-Li
    Liang, Jie
    Zhai, Hui-Hong
    Zhang, Hong-Bo
    Guo, Xue-Gang
    Wu, Kai-Chun
    Xu, Yan-Ming
    Jia, Lin-Tao
    Yang, An-Gang
    Chen, Si-Yi
    Fan, Dai-Ming
    GUT, 2010, 59 (03) : 292 - 299
  • [23] Polymer-lipid hybrid anti-HER2 nanoparticles for targeted salinomycin delivery to HER2-positive breast cancer stem cells and cancer cells
    Li, Jun
    Xu, Wenqing
    Yuan, Xiaoli
    Chen, Huaiwen
    Song, Hao
    Wang, Bingquan
    Han, Jun
    INTERNATIONAL JOURNAL OF NANOMEDICINE, 2017, 12 : 6909 - 6921
  • [24] AAV-Mediated Riboswitch-Controlled Delivery of Anti-HER2 Antibody Suppresses HER2-Positive Tumorigenesis
    Wang, George
    Zhong, Zhaojing
    Oh, Jae Gyun
    Waksal, Samuel
    Forbes, Alexandria
    Guo, Xuecui
    MOLECULAR THERAPY, 2023, 31 (04) : 661 - 661
  • [25] Anti-HER2 antibody therapy using gene-transduced adipocytes for HER2-positive breast cancer
    Takahito Masuda
    Hiroshi Fujimoto
    Ryotaro Teranaka
    Masayuki Kuroda
    Yasuyuki Aoyagi
    Takeshi Nagashima
    Takafumi Sangai
    Mamoru Takada
    Ayako Nakagawa
    Yoshitaka Kubota
    Koutaro Yokote
    Masayuki Ohtsuka
    Breast Cancer Research and Treatment, 2020, 180 : 625 - 634
  • [26] Suppression of tumor growth in human gastric cancer with HER2 overexpression by an anti-HER2 antibody in a murine model
    Matsui, Y
    Inomata, M
    Tojigamori, M
    Sonoda, K
    Shiraishi, N
    Kitano, S
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2005, 27 (03) : 681 - 685
  • [27] Anti-HER2 antibody therapy using gene-transduced adipocytes for HER2-positive breast cancer
    Masuda, Takahito
    Fujimoto, Hiroshi
    Teranaka, Ryotaro
    Kuroda, Masayuki
    Aoyagi, Yasuyuki
    Nagashima, Takeshi
    Sangai, Takafumi
    Takada, Mamoru
    Nakagawa, Ayako
    Kubota, Yoshitaka
    Yokote, Koutaro
    Ohtsuka, Masayuki
    BREAST CANCER RESEARCH AND TREATMENT, 2020, 180 (03) : 625 - 634
  • [28] Therapeutic potential of a novel IP-10-(anti-HER2 scFv) fusion protein for the treatment of HER2-positive breast cancer
    Ahmadzadeh, Maryam
    Mohit, Elham
    BIOTECHNOLOGY LETTERS, 2023, 45 (03) : 371 - 385
  • [29] Therapeutic potential of a novel IP-10-(anti-HER2 scFv) fusion protein for the treatment of HER2-positive breast cancer
    Maryam Ahmadzadeh
    Elham Mohit
    Biotechnology Letters, 2023, 45 : 371 - 385
  • [30] Anti-HER2 antibody enhances the growth inhibitory effect of anti-oestrogen on breast cancer cells expressing both oestrogen receptors and HER2
    Kunisue H.
    Kurebayashi J.
    Otsuki T.
    Tang C.K.
    Kurosumi M.
    Yamamoto S.
    Tanaka K.
    Doihara H.
    Shimizu N.
    Sonoo H.
    British Journal of Cancer, 2000, 82 (1) : 46 - 51
12345